Abstract：ObjectiveTo explore the clinical effect of transurethral bladder tumor vaporizing electrotomy combined with epi in the treatment of non-muscular infiltrating bladder cancer.Methods40 patients of non-muscle invasive bladder cancer treated in our hospital from March 2014 to March 2016 were divided into observation group (n=20)and control group (n=20).Two groups were given transurethral electrovaporization of bladder tumor treatment,the control group with hydroxycamptothecin or mitoxantrone for bladder perfusion,observation group with epirubicin for bladder perfusion.The catheter indwelling time,operation time,adverse reactions and recurrence were compared between the two groups.ResultsThere was no significant difference in indwelling time and operation time between the two groups(P>0.05).There was no significant difference in the incidence of adverse reactions between the two groups(χ2=0.28,P=0.60).There was no significant difference in recurrence rate between the two groups (χ2=0.20,P=0.66).ConclusionTransurethral electrovaporization resection of bladder tumor combined with epirubicin in the treatment of non-muscle invasive bladder cancer is effective,the recurrence rate is low,worthy of promotion.
京公网安备 11010502046607号